4.5 Article

MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-B Signaling

Hidetaka Kawabata et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Review Biochemistry & Molecular Biology

TRIM Family Proteins: Roles in Autophagy, Immunity, and Carcinogenesis

Shigetsugu Hatakeyama

TRENDS IN BIOCHEMICAL SCIENCES (2017)

Article Oncology

miRNA-101 Suppresses Epithelial-to-mesenchymal Transition by Targeting HMGA2 in Pancreatic Cancer Cells

Wenli Jiang et al.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2016)

Article Oncology

miR-101 inhibits glioma cell invasion via the downregulation of COX-2

Chunyang Ma et al.

ONCOLOGY LETTERS (2016)

Article Cell Biology

Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes

Shuhua Zhao et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2015)

Article Oncology

Amplification of TRIM44: Pairing a Prognostic Target With Potential Therapeutic Strategy

Chin-Ann Johnny Ong et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)

Article Oncology

miRNA-101: A potential target for tumor therapy

Ting Gui et al.

CANCER EPIDEMIOLOGY (2012)

Review Oncology

TRIM proteins and cancer

Shigetsugu Hatakeyama

NATURE REVIEWS CANCER (2011)

Article Pharmacology & Pharmacy

Current Therapeutic Paradigms in Glioblastoma

Allison Quick et al.

REVIEWS ON RECENT CLINICAL TRIALS (2010)

Article Medicine, General & Internal

Central nervous system tumors

Jan C. Buckner et al.

MAYO CLINIC PROCEEDINGS (2007)